Recent advances in cancer pain management

F1000Prime Reports

Volumn 6, Issue , 2014, Pages

  Wilson, James ^a   Stack, Catherine ^b   Hester, Joan ^b  

^a ST GEORGE S HOSPITAL   (United Kingdom)

^b KING S COLLEGE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84894239506     PISSN: None     EISSN: 20517599     Source Type: Journal    
DOI: 10.12703/P6-10     Document Type: Review

References (66)

1. Bonica J VV, Twycross RG: Cancer pain. In The Management of Pain. 2nd edition. Philadelphia: Lea and Febiger; 1990, 400-401.
2. WHO: Cancer Pain Relief. In Geneva; 1986.
3. Twycross R, Harcourt J, Bergl S: A survey of pain in patients with advanced cancer. J Pain Symptom Manage 1996, 12:273-82. (Pubitemid 26362301)
4. Weiss SC, Emanuel LL, Fairclough DL, Emanuel EJ: Understanding the experience of pain in terminally ill patients. Lancet 2001, 357:1311-5. (Pubitemid 32441527)
5. Seyfried O, Hester J: Opioids and Endocrine Dysfunction. British Journal of Pain 2012, 6(1):17-24.
6. Rajagopal A, Vassilopoulou-Sellin R, Palmer JL, Kaur G, Bruera E: Symptomatic hypogonadism in male survivors of cancer with chronic exposure to opioids. Cancer 2004, 100:851-8. (Pubitemid 38176866)
7. Schmidt BL, Hamamoto DT, Simone DA, Wilcox GL: Mechanism of cancer pain. Mol Interv 2010, 10:164-78.
8. Ghilardi JR, Röhrich H, Lindsay TH, Sevcik MA, Schwei MJ, Kubota K, Halvorson KG, Poblete J, Chaplan SR, Dubin AE, Carruthers NI, Swanson D, Kuskowski M, Flores CM, Julius D, Mantyh PW: Selective blockade of the capsaicin receptor TRPV1 attenuates bone cancer pain. J Neurosci 2005, 25:3126-31. (Pubitemid 40463547)
9. Nagae M, Hiraga T, Yoneda T: Acidic microenvironment created by osteoclasts causes bone pain associated with tumor colonization. J Bone Miner Metab 2007, 25:99-104. (Pubitemid 46328665)
10. Nelson J, Bagnato A, Battistini B, Nisen P: The endothelin axis: emerging role in cancer. Nat Rev Cancer 2003, 3:110-6. (Pubitemid 37328878)
11. Cain DM, Wacnik PW, Turner M, Wendelschafer-Crabb G, Kennedy WR, Wilcox GL, Simone DA: Functional interactions between tumor and peripheral nerve: changes in excitability and morphology of primary afferent fibers in a murine model of cancer pain. J Neurosci 2001, 21:9367-76. (Pubitemid 33096880)
12. Wacnik PW, Eikmeier LJ, Ruggles TR, Ramnaraine ML, Walcheck BK, Beitz AJ, Wilcox GL: Functional interactions between tumor and peripheral nerve: morphology, algogen identification, and behavioral characterization of a new murine model of cancer pain. J Neurosci 2001, 21:9355-66. (Pubitemid 33096879)
13. Quang PN, Schmidt BL: Peripheral endothelin B receptor agonist-induced antinociception involves endogenous opioids in mice. Pain 2010, 149:254-62.
14. Quang P, Schmidt B: Endothelin receptor-mediated attenuation of carcinoma-induced nociception is opioid-dependent in mice. The Journal of Pain 2009, 10(4, suppl):S22.
15. Sevcik MA, Ghilardi JR, Halvorson KG, Lindsay TH, Kubota K, Mantyh PW: Analgesic efficacy of bradykinin B1 antagonists in a murine bone cancer pain model. J Pain 2005, 6:771-5. (Pubitemid 41579075)
16. Fujita M, Andoh T, Ohashi K, Akira A, Saiki I, Kuraishi Y: Roles of kinin B1 and B2 receptors in skin cancer pain produced by orthotopic melanoma inoculation in mice. Eur J Pain 2010, 14:588-94.
17. Constantin CE, Mair N, Sailer CA, Andratsch M, Xu Z, Blumer MJF, Scherbakov N, Davis JB, Bluethmann H, Ji R, Kress M: Endogenous tumor necrosis factor alpha (TNFalpha) requires TNF receptor type 2 to generate heat hyperalgesia in a mouse cancer model. J Neurosci 2008, 28:5072-81.
18. Lam DK, Schmidt BL: Serine proteases and protease-activated receptor 2-dependent allodynia: a novel cancer pain pathway. Pain 2010, 149:263-72.
19. Gordon-Williams RM, Dickenson AH: Central neuronal mechanisms in cancer-induced bone pain. Curr Opin Support Palliat Care 2007, 1:6-10.
20. Bell RF, Eccleston C, Kalso EA: Ketamine as an adjuvant to opioids for cancer pain. Cochrane Database Syst Rev 2012, 11:CD003351.
21. Currie GL, Delaney A, Bennett MI, Dickenson AH, Egan KJ, Vesterinen HM, Sena ES, Macleod MR, Colvin LA, Fallon MT: Animal models of bone cancer pain: systematic review and meta-analyses. Pain 2013, 154:917-26.
22. Mishra S, Bhatnagar S, Goyal GN, Rana SPS, Upadhya SP: A comparative efficacy of amitriptyline, gabapentin, and pregabalin in neuropathic cancer pain: a prospective randomized double-blind placebo-controlled study. Am J Hosp Palliat Care 2012, 29:177-82.
23. Smith EML, Pang H, Cirrincione C, Fleishman S, Paskett ED, Ahles T, Bressler LR, Fadul CE, Knox C, Le-Lindqwister N, Gilman PB, Shapiro CL: Effect of duloxetine on pain, function, and quality of life among patients with chemotherapy-induced painful peripheral neuropathy: a randomized clinical trial. JAMA 2013, 309:1359-67.
24. Mercadante S, Porzio G, Ferrera P, Aielli F, Adile C, Ficorella C, Giarratano A, Casuccio A: Tapentadol in cancer pain management: a prospective open-label study. Curr Med Res Opin 2012, 28:1775-9.
25. Derry S, Lloyd R, Moore RA, McQuay HJ: Topical capsaicin for chronic neuropathic pain in adults. Cochrane Database Syst Rev 2009, CD007393.
26. Mick G, Correa-Illanes G: Topical pain management with the 5% lidocaine medicated plaster - a review. Curr Med Res Opin 2012, 28:937-51.
27. de Leon-Casasola OA, Medicis ED: My patient with rectal cancer does not have pain control despite high doses of opioids and optimal doses of gabapentin and desipramine. Now what?-Advanced strategies for cancer pain management. Techniques in Regional Anaesthesia and Pain Management 2000, 4: 167-173.
28. Williams JE, Grady K: Pain News: Intrathecal drug delivery for the management of pain and spasticity in adults; a national audit. BPS National Intrathecal Drug Audit group2008, [http://www.britishpainsociety.org/bps-nl- winter-2008.pdf].
29. Smith TJ, Staats PS, Deer T, Stearns LJ, Rauck RL, Boortz-Marx RL, Buchser E, Català E, Bryce DA, Coyne PJ, Pool GE: Randomized clinical trial of an implantable drug delivery system compared with comprehensive medical management for refractory cancer pain: impact on pain, drug-related toxicity, and survival. J Clin Oncol 2002, 20:4040-9.
30. Burton AW, Rajagopal A, Shah HN, Mendoza T, Cleeland C, Hassenbusch SJ, Arens JF: Epidural and intrathecal analgesia is effective in treating refractory cancer pain. Pain Med 2004, 5:239-47. (Pubitemid 39369243)
31. Deer TR, Smith HS, Burton AW, Pope JE, Doleys DM, Levy RM, Staats PS, Wallace MS, Webster LR, Rauck RL, Cousins M: Comprehensive consensus based guidelines on intrathecal drug delivery systems in the treatment of pain caused by cancer pain. Pain Physician 2011, 14:E283-312.
32. Upadhyay SP, Mallick PN: Intrathecal drug delivery system (IDDS) for cancer pain management: a review and updates. Am J Hosp Palliat Care 2012, 29:388-98.
33. DRURY AB, PALMER PH, HIGHMAN WJ: CARCINOMATOUS METASTASIS TO THE VERTEBRAL BODIES. J Clin Pathol 1964, 17:448-57.
34. Chew C, Craig L, Edwards R, Moss J, O'Dwyer PJ: Safety and efficacy of percutaneous vertebroplasty in malignancy: a systematic review. Clin Radiol 2011, 66:63-72.
35. Chew C, Ritchie M, O'Dwyer PJ, Edwards R: A prospective study of percutaneous vertebroplasty in patients with myeloma and spinal metastases. Clin Radiol 2011, 66:1193-6.
36. Jackson MB, Pounder D, Price C, Matthews AW, Neville E: Percutaneous cervical cordotomy for the control of pain in patients with pleural mesothelioma. Thorax 1999, 54:238-41. (Pubitemid 29110504)
37. Davies DD: Incidence of major complications of neurolytic coeliac plexus block. J R Soc Med 1993, 86:264-6.
38. Wong GY, Schroeder DR, Carns PE, Wilson JL, Martin DP, Kinney MO, Mantilla CB, Warner DO: Effect of neurolytic celiac plexus block on pain relief, quality of life, and survival in patients with unresectable pancreatic cancer: a randomized controlled trial. JAMA 2004, 291:1092-9. (Pubitemid 38541686)
39. Polati E, Finco G, Gottin L, Bassi C, Pederzoli P, Ischia S: Prospective randomized double-blind trial of neurolytic coeliac plexus block in patients with pancreatic cancer. Br J Surg 1998, 85:199-201. (Pubitemid 28099937)
40. Arcidiacono PG, Calori G, Carrara S, McNicol ED, Testoni PA: Celiac plexus block for pancreatic cancer pain in adults. Cochrane Database Syst Rev 2011, CD007519.
41. Stefaniak T, Basinski A, Vingerhoets A, Makarewicz W, Connor S, Kaska L, Stanek A, Kwiecinska B, Lachinski AJ, Sledzinski Z: A comparison of two invasive techniques in the management of intractable pain due to inoperable pancreatic cancer: neurolytic celiac plexus block and videothoracoscopic splanchnicectomy. Eur J Surg Oncol 2005, 31:768-73. (Pubitemid 41194655)
42. Slatkin NE, Rhiner M: Phenol saddle blocks for intractable pain at end of life: report of four cases and literature review. Am J Hosp Palliat Care 2003, 20:62-6. (Pubitemid 39387668)
43. Tran DQH, Clemente A, Tran DQ, Finlayson RJ: A comparison between ultrasound-guided infraclavicular block using the "double bubble" sign and neurostimulation-guided axillary block. Anesth Analg 2008, 107:1075-8.
44. McQuay HJ, Collins SL, Carroll D, Moore RA: Radiotherapy for the palliation of painful bone metastases. Cochrane Database Syst Rev 2000: CD001793.
45. Chow E, Harris K, Fan G, Tsao M, Sze WM: Palliative radiotherapy trials for bone metastases: a systematic review. J Clin Oncol 2007, 25:1423-36. (Pubitemid 46706892)
46. Lutz S, Berk L, Chang E, Chow E, Hahn C, Hoskin P, Howell D, Konski A, Kachnic L, Lo S, Sahgal A, Silverman L, Gunten C von, Mendel E, Vassil A, Bruner DW, Hartsell W: Palliative radiotherapy for bone metastases: an ASTRO evidence-based guideline. Int J Radiat Oncol Biol Phys 2011, 79:965-76.
47. Nilsson S, Franzén L, Parker C, Tyrrell C, Blom R, Tennvall J, Lennernäs B, Petersson U, Johannessen DC, Sokal M, Pigott K, O'Bryan-Tear CG, Thuresson M, Bolstad B, Bruland ØS: Two-year survival follow-up of the randomized, double-blind, placebo-controlled phase II study of radium-223 chloride in patients with castration-resistant prostate cancer and bone metastases. Clin Genitourin Cancer 2013, 11:20-6.
48. Coleman RE, Guise TA, Lipton A, Roodman GD, Berenson JR, Body J, Boyce BF, Calvi LM, Hadji P, McCloskey EV, Saad F, Smith MR, Suva LJ, Taichman RS, Vessella RL, Weilbaecher KN: Advancing treatment for metastatic bone cancer: consensus recommendations from the Second Cambridge Conference. Clin Cancer Res 2008, 14:6387-95.
49. Wong R, Wiffen PJ: Bisphosphonates for the relief of pain secondary to bone metastases. Cochrane Database Syst Rev 2002: CD002068.
50. Linch M: Cancer treatments for Pain Relief. In. Royal Marsden Hospital; 2013.
51. van Buyten J, Al-Kaisy A, Smet I, Palmisani S, Smith T: High-frequency spinal cord stimulation for the treatment of chronic back pain patients: results of a prospectivemulticenter European clinical study. Neuromodulation 2013, 16:59-65 discussion 65-6.
52. Lihua P, Su M, Zejun Z, Ke W, Bennett MI: Spinal cord stimulation for cancer-related pain in adults. Cochrane Database Syst Rev 2013, 2:CD009389.
53. Shimoji K, Hokari T, Kano T, Tomita M, Kimura R, Watanabe S, Endoh H, Fukuda S, Fujiwara N, Aida S: Management of intractable pain with percutaneous epidural spinal cord stimulation: differences in pain-relieving effects among diseases and sites of pain. Anesth Analg 1993, 77:110-6. (Pubitemid 23200967)
54. Yakovlev AE, Resch BE, Karasev SA: Treatment of cancer-related chest wall pain using spinal cord stimulation. Am J Hosp Palliat Care 2010: 27:552-6.
55. Yakovlev AE, Resch BE: Spinal cord stimulation for cancer-related low back pain. Am J Hosp Palliat Care 2012, 29:93-7.
56. Cata JP, Cordella JV, Burton AW, Hassenbusch SJ, Weng H, Dougherty PM: Spinal cord stimulation relieves chemotherapy-induced pain: a clinical case report. J Pain Symptom Manage 2004, 27:72-8. (Pubitemid 38050250)
57. Tsubota S, Higaki N, Nagaro T: [A case of neuropathic cancer pain in the lower extremities successfully treated with spinal cord stimulation]. Masui 2009, 58:1460-1.
58. Yakovlev AE, Ellias Y: Spinal cord stimulation as a treatment option for intractable neuropathic cancer pain. Clin Med Res 2008, 6:103-6.
59. Nouri KH, Brish EL: Spinal cord stimulation for testicular pain. Pain Med 2011, 12:1435-8.
60. Bardia A, Barton DL, Prokop LJ, Bauer BA, Moynihan TJ: Efficacy of complementary and alternative medicine therapies in relieving cancer pain: a systematic review. J Clin Oncol 2006, 24:5457-64. (Pubitemid 46623180)
61. NICE clinical guideline 140: Opioids in palliative care: safe and effective prescribing of strong opioids for pain in palliative care in adults. National Institute for Health and Clinical Excellence2012, [http://www.nice.org. uk/nicemedia/live/13745/59285/59285.pdf].
62. Blanchard H, Batten B: Designing and producing a patient leaflet on morphine. Eu J Pall Care 1996, 3:106-8.
63. Bender JL, Hohenadel J, Wong J, Katz J, Ferris LE, Shobbrook C, Warr D, Jadad AR: What patients with cancer want to know about pain: a qualitative study. J Pain Symptom Manage 2008, 35:177-87.
64. Reid CM, Gooberman-Hill R, Hanks GW: Opioid analgesics for cancer pain: symptom control for the living or comfort for the dying? A qualitative study to investigate the factors influencing the decision to accept morphine for pain caused by cancer. Ann Oncol 2008, 19:44-8.
65. Bennett MI, Bagnall A, José Closs S: How effective are patient-based educational interventions in the management of cancer pain? Systematic review and meta-analysis. Pain 2009, 143:192-9.
66. Ling C, Lui LYY, So WKW: Do educational interventions improve cancer patients' quality of life and reduce pain intensity? Quantitative systematic review. J Adv Nurs 2012, 68:511-20.